MedPath

Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

Completed
Conditions
Bladder Function
Interventions
Procedure: cystometry
Procedure: polysomnography
Registration Number
NCT01029015
Lead Sponsor
Astellas Pharma Inc
Brief Summary

This is an observational, physiology pilot study of subjects with overactive bladder, insomnia and normal subjects. No study drug will be given. All subjects will complete a one week sleep diary and a 3-day bladder diary. After one week, subjects meeting eligibility requirements will complete a single sleep night stay in a sleep laboratory setting. During the sleep night stay, subjects will be evaluated using cystometry and polysomnography. In the morning following the sleep night stay, subjects will complete a sleep questionnaire and this will complete their participation in the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Must not have a urinary tract infection

  • Time in bed between 6.5 and 9 hours for at least 5 nights per week for preceding month

  • Usual bed time is before midnight (24:00 hours) and typically does not vary by ± 1 hour for preceding month

  • OAB subjects

    • OAB symptoms for >= 3 months
    • Documented detrusor overactivity episodes within 6 months
  • Insomnia subjects

    • Diagnosis of chronic primary insomnia
    • History of > 1 month of waking up more than 2 times per night and being awake for more than 60 minutes per night for at least 3 months
Read More
Exclusion Criteria
  • Diagnosis of both OAB and primary insomnia
  • Diagnosis of nocturnal polyuria
  • Diagnosis of BPH
  • BMI >= 34
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 1 -OABcystometrySubjects with overactive bladder (OAB)
Group 1 -OABpolysomnographySubjects with overactive bladder (OAB)
Group 2 - InsomniacystometrySubjects with insomnia
Group 2 - InsomniapolysomnographySubjects with insomnia
Group 3 - NormalcystometryNormal Subjects
Group 3 - NormalpolysomnographyNormal Subjects
Primary Outcome Measures
NameTimeMethod
Number and proportion of voids associated with urgencyDuring night in sleep lab
Number and proportion of voids associated with Detrusor Overactivity episodes within 10 minutes prior to the polysomnography (PSG) awakeningsDuring night in sleep lab
Time from PSG awakening to each void in minutesDuring night in sleep lab
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath